Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

» DHRM's 10-Y Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DHRM

No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )


P/S 1.80
DHRM's P/S is ranked higher than
69% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. DHRM: 1.80 )
DHRM' s 10-Year P/S Range
Min: 0   Max: 1.8
Current: 1.8

EV-to-EBIT 15.90
DHRM's EV-to-EBIT is ranked higher than
76% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 20.91 vs. DHRM: 15.90 )
DHRM' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 15.9

Valuation & Return


Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:J8D.Germany
Dehaier Medical Systems Ltd., was incorporated in the British Virgin Islands in 2003 as a limited liability company. The Company is in the business of developing and distributing medical devices. It distributes products designed and manufactured by other companies. The Company broadens its product portfolio through distribution agreements with international manufacturers, and the products it distributes are imported. Its distribution offerings are mostly equipment used in the operating room, the intensive care unit ('ICU') and the emergency room. Besides distributing medical devices, it also design, develop and market its own proprietary products and medical components. Because it does not run any manufacturing facilities, it contracts some of the medical components to outside manufacturers in China. Its proprietary products require light assembly by it before distribution. Its proprietary and distributed products include two major categories: medical devices (including supporting products); and sleep respiratory and oxygen therapy products (previously defined as respiratory and oxygen homecare products). Its medical devices proprietary and distributed products are mainly used in hospitals and clinics, while the sleep respiratory and oxygen therapy products are mainly for hospitals, sleep centers, at-home use by individual, emergency center, national defense and national disaster relief circumstances. It sells its products primarily through distributors, but it also makes direct sales to hospitals, clinics, government health bureaus, government organizations and individuals. It continue to further its market reach by introducing newer and more advanced product lines that address different end-user needs. Its competitors include publicly traded and privately held multinational companies, such as Respironics, Inc., ResMed Inc., and Covidien, as well as domestic Chinese companies such as Beijing Aoji, Beijing Ya'ao, Jiangsu Yuyue and Zhejiang Longfei. Its products are medical devices and are subject to regulatory controls governing medical devices. As a distributor of medical equipment and supplies it is subject to regulation and oversight by different levels of the food and drug administration in China, in particular the SFDA. It is also subject to other PRC government laws and regulations.

Personalized Checklist

Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial